Results 31 to 40 of about 1,693 (197)

Modern tocolysis and adverse effects of tocolytics [PDF]

open access: yesГинекология, 2018
Relevance. Toсolytic therapy is the only method that is used in the treatment of pregnant women with preterm labor. However, the effectiveness and safety of this therapy is still a matter of debate.
O R Baev   +2 more
doaj   +1 more source

A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment

open access: yesReproductive Biology and Endocrinology, 2022
Background Patients with recurrent implantation failure (RIF) may have more uterine contractions. Several observational studies suggested that atosiban administration around embryo transfer resulted in higher pregnancy rates in RIF patients.
Chuan Ling Tang   +14 more
doaj   +1 more source

СРАВНЕНИЕ ТОКОЛИЗА ГЕКСОПРЕНАЛИНОМ И АТОЗИБАНОМ

open access: yesМедицинский совет, 2017
The aim of the study was to compare the efficacy and safety of tocolytic agents - atosiban and hexoprenaline.Patients and methods: The study included 119 pregnant women with threatening preterm labour between 28 to 34 weeks of gestation.
О. Р. Баев   +4 more
doaj   +1 more source

A multicenter, retrospective comparison of pregnancy outcomes between groups of preterm labor nulliparous mothers treated with atosiban vs. ritodrine in singleton and multiple pregnancies

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2023
Objective: To evaluate the safety and efficacy of atosiban and ritodrine in pregnant women who were hospitalized for threatened preterm labor (TPL). Materials and methods: Diagnosis records of preterm labor and subsequent pregnancy-related records and ...
Guk Won Kim   +5 more
doaj   +1 more source

Pregnancy-Associated Isolated Fallopian Tube Torsion With a True Knot Managed by Laparoscopic Salpingectomy: A Case Report. [PDF]

open access: yesCase Rep Obstet Gynecol
Isolated torsion of the fallopian tube is a rare cause of acute abdomen in women of reproductive age, with an estimated annual incidence of approximately one per 1.5 million women. Its occurrence during pregnancy is rarer still, with fewer than 50 cases published.
Abdeltawab A.
europepmc   +2 more sources

Atosiban vs. ritodrine as a tocolytic in external cephalic version at term: a prospective cohort study [PDF]

open access: yes, 2009
Objective: To compare the success rate of external cephalic version (ECV) at term using ritodrine or atosiban as a tocolytic agent. Study design: Prospective cohort study with a sample of 236 pregnant women with a breech presentation at term, from ...
Eguiguren, Nekane   +13 more
core   +2 more sources

Atosiban versus nifedipine for the management of preterm labor: a systematic review and meta-analysis of randomized controlled trials [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
Objective: To compare the efficacy, maternal safety, and neonatal outcomes of atosiban versus nifedipine in the management of preterm labor, with particular attention to neonatal intensive care unit (NICU) admission rates.
Alessandro Pascon Filho   +5 more
doaj   +2 more sources

Tocolytic agents and the failure to improve neonatal outcomes. [PDF]

open access: yesPregnancy (Hoboken)
Abstract Premature delivery has long been a major problem in obstetrics. Increased perinatal morbidity and mortality as well as substantial health care costs, both short and long term, have driven the efforts to combat this complication. While multiple agents have been studied over the last 70 years leading to hundreds of publications and involving ...
FitzSimmons J, Oliver E.
europepmc   +2 more sources

Computerized Evaluation of Fetal Heart Rate during Tocolytic Treatment: Comparison between Atosiban and Ritodrine.

open access: yes, 2009
We compared the effects of ritodrine and atosiban treatments on fetal cardiovascular behavior by computerized nonstress test (c-NST) analysis. Women diagnosed with preterm labor were randomized to receive either atosiban or ritodrine.
NERI, Isabella   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy